07:00 , Oct 7, 2013 |  BioCentury  |  Finance

4Q Financial Markets Preview: Totally baked

The fourth quarter will see buysiders focused on news in cancer and HCV from big clinical meetings and expected PDUFA decisions, as well as several large cap commercial launches. But investors warned some milestones are...
08:00 , Jan 21, 2013 |  BC Week In Review  |  Clinical News

Budenofalk budesonide gastro-resistant capsule regulatory update

The Scottish Medicines Consortium recommended the use of Dr. Falk's Budenofalk budesonide gastro-resistant capsule on the National Health Service (NHS) in Scotland to treat chronic diarrhea due to collagenous colitis - its approved indication. In...
07:00 , Mar 17, 2008 |  BC Week In Review  |  Company News

Dr. Falk Pharma, Salix deal

Dr. Falk granted Salix an exclusive license to develop and commercialize budesonide products in the U.S. The products include budesonide rectal foam , which is expected to start Phase III testing late this year or...